Literature DB >> 23872409

Sweet memories: 20 years of progress in research on cognitive functioning in diabetes.

Geert Jan Biessels1.   

Abstract

This paper appears in a special issue of the European Journal of Pharmacology that commemorates the retirement of Professor Willem Hendrik Gispen as distinguished professor of Utrecht University and as editor of the European Journal of Pharmacology. The paper provides an overview of a research line on the impact of diabetes on cognition that we started together 20 years ago, and that continues to this day. I will report how we more or less stumbled upon this topic, that was understudied, but proved to be of definite clinical relevance. I will discuss how we tried to establish animal models, how developments from clinical and experimental studies from around the world led us to reconsider our concepts, and how findings from research on diabetic neuropathy, insulin signaling in the brain, Alzheimer's disease and dementia, and vascular disease and stroke converged and helped to create new ideas and refute others. This voyage has not ended yet, because the ultimate goal is to offer patients with diabetes treatment that can protect them against accelerated cognitive decline. Although this could take another 20 years, the research from Willem Hendrik and his group brought us an important step in the right direction.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer′s disease; Brain; Cognitive dysfunction; Dementia; Diabetes mellitus; Magnetic resonance imaging

Mesh:

Substances:

Year:  2013        PMID: 23872409     DOI: 10.1016/j.ejphar.2013.04.055

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  [Nicorandil improves cognitive dysfunction in mice with streptozotocin-induced diabetes].

Authors:  Wen-Hui Yan; Chun-Xi Zhang; Tong Xing; Xue Gong; Yu-Xuan Yang; Yi-Nuo Li; Xuan Liu; Jiamaliding Ayijiang; Ye Yu; Meng Zhang; Li-Na Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

2.  Brain functional networks: correlation analysis with clinical indexes in patients with diabetic retinopathy.

Authors:  Hui Dai; Yu Zhang; Lillian Lai; Su Hu; Ximing Wang; Yonggang Li; Chunhong Hu; Hailin Shen
Journal:  Neuroradiology       Date:  2017-08-22       Impact factor: 2.804

3.  The Relationship Between the Score on a Simple Measure of Cognitive Function and Incident CVD in People With Diabetes: A Post Hoc Epidemiological Analysis From the ACCORD-MIND Study.

Authors:  Tali Cukierman-Yaffe; Hertzel C Gerstein; Michael E Miller; Lenore J Launer; Jeff D Williamson; Karen R Horowitz; Faramarz Ismail-Beigi; Ronald M Lazar
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

4.  Metabolic Syndrome and its Profound Effect on Prevalence of Ischemic Stroke.

Authors:  Brandon P Lucke-Wold; Kenneth DiPasquale; Aric F Logsdon; Linda Nguyen; A Noelle Lucke-Wold; Ryan C Turner; Jason D Huber; Charles L Rosen
Journal:  Am Med Stud Res J       Date:  2014

5.  Peripheral glucose levels and cognitive outcome after ischemic stroke-Results from the Munich Stroke Cohort.

Authors:  Vera Zietemann; Frank Arne Wollenweber; Anna Bayer-Karpinska; Geert Jan Biessels; Martin Dichgans
Journal:  Eur Stroke J       Date:  2016-03-01

6.  Acutely elevated O-GlcNAcylation suppresses hippocampal activity by modulating both intrinsic and synaptic excitability factors.

Authors:  Hongik Hwang; Hyewhon Rhim
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

7.  Azilsartan protects against hyperglycemia-induced hyperpermeability of the blood-brain barrier.

Authors:  Jing Han; Hua Tang; Longfei Yao; Erliang Jin; Wanxi Pan; Shaojun Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.